Evorpacept has received FDA fast track and orphan drug designations for HER-2 positive gastric or GEJ carcinoma. In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet ...

How might the phase 3 KEYNOTE-689 trial results influence clinical practice for resectable locally advanced head and neck squamous cell carcinoma? What is needed to support the broader adoption of ...

“Fold the wings ... and reduce drag. “Wings play a really important part in our decarbonisation journey by bringing aerodynamic efficiency,” says Sue Partridge. She is head of the Airbus ...

"I hate this place but should be another fun ambulance bill," wrote the RHOBH alum, who has struggled with a mystery illness that has resulted in severe facial disfigurement for nearly two years.

“Fold the wings ... The aim: to increase lift and reduce drag. “Wings play a really important part in our decarbonisation journey by bringing aerodynamic efficiency,” says Sue Partridge. She is head ...

MSUM needs to replace Tim Bergstraser, who has been named head coach at Denver. Bergstraser won 75 games in three seasons as Dragons head coach. Minnesota State Moorhead athletic director Chad ...

That latest positive trial proves that ivonescimab’s head-to-head win against Keytruda as NSCLC monotherapies in the HARMONi-2 study was not a “one hit wonder,” Citi analyst Yigal ...

Dragons head coach Filo Tiatia has warned that the Ospreys will be desperate to avenge their opening-weekend defeat at Rodney Parade when the sides meet at the Swansea.com Stadium on Saturday.

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.

The FDA has started a priority review of MSD's Keytruda as neoadjuvant and adjuvant treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), with a decision due by 23rd June.